356 related articles for article (PubMed ID: 23948879)
1. Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease.
Sorensen KC; Simonsen AH; Holmetoft UB; Hasselbalch SG; Heegaard NH
J Alzheimers Dis; 2013; 37(2):379-87. PubMed ID: 23948879
[TBL] [Abstract][Full Text] [Related]
2. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
Maetzler W; Stoycheva V; Schmid B; Schulte C; Hauser AK; Brockmann K; Melms A; Gasser T; Berg D
J Alzheimers Dis; 2010; 22(3):933-8. PubMed ID: 20858953
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
[TBL] [Abstract][Full Text] [Related]
4. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
[TBL] [Abstract][Full Text] [Related]
5. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease.
Maruyama M; Higuchi M; Takaki Y; Matsuba Y; Tanji H; Nemoto M; Tomita N; Matsui T; Iwata N; Mizukami H; Muramatsu S; Ozawa K; Saido TC; Arai H; Sasaki H
Ann Neurol; 2005 Jun; 57(6):832-42. PubMed ID: 15929037
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.
Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Otto M; Kornhuber J; Rüther E; Wiltfang J
Dement Geriatr Cogn Disord; 2011; 31(1):37-44. PubMed ID: 21135556
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
10. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
[TBL] [Abstract][Full Text] [Related]
11. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.
Laske C; Stransky E; Fritsche A; Eschweiler GW; Leyhe T
Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):80-5. PubMed ID: 18806919
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
[TBL] [Abstract][Full Text] [Related]
13. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
[TBL] [Abstract][Full Text] [Related]
14. Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease.
Salza R; Oudart JB; Ramont L; Maquart FX; Bakchine S; Thoannès H; Ricard-Blum S
J Alzheimers Dis; 2015; 44(4):1253-61. PubMed ID: 25408220
[TBL] [Abstract][Full Text] [Related]
15. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R
J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.
Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB
Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492
[TBL] [Abstract][Full Text] [Related]
18. Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.
Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Boulanghien J; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Perret-Liaudet A; Touchon J; Lehmann S
J Alzheimers Dis; 2011; 26(3):553-63. PubMed ID: 21709372
[TBL] [Abstract][Full Text] [Related]
19. Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis.
Luo X; Shi H; Hou L; Zhong X; Chen X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chen J; Fang Y; He H; Ning Y
Eur J Neurol; 2015 May; 22(5):853-8. PubMed ID: 25707998
[TBL] [Abstract][Full Text] [Related]
20. Interrelations between CSF soluble AβPPβ, amyloid-β 1-42, SORL1, and tau levels in Alzheimer's disease.
Alexopoulos P; Guo LH; Tsolakidou A; Kratzer M; Grimmer T; Westerteicher C; Jiang M; Bujo H; Diehl-Schmid J; Kurz A; Perneczky R
J Alzheimers Dis; 2012; 28(3):543-52. PubMed ID: 22045485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
